Historical record - last NADAC effective date: 8/21/2024
Product Information
MAR-COF CG LIQUID is a generic product labeled by Marnel Pharmaceuticals, Inc., priced at $0.1471 per ML under NDC 00682047516. Its NADAC has been published 418 times since May 21, 2014.
Strength
7.5; 225 mg/5mL; mg/5mL
Manufacturer
Marnel Pharmaceuticals, Inc.NDC
00682047516
Classification
Generic
Dosage Form
SYRUP
Route
ORAL
Effective Date
8/21/2024
Active Ingredients
CODEINE PHOSPHATE; GUAIFENESINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
12/1/2008
Pharmacological Classes
Price Statistics
The NADAC for MAR-COF CG LIQUID has been published 418 times since May 21, 2014, and over the history we have for it it has risen 50.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1471 per ML |
|---|---|
| All-time high | $0.1557 (Feb 10, 2016) |
| All-time low | $0.0976 (May 21, 2014) |
| Median price | $0.1441 |
| Average price | $0.1398 |
| Largest weekly change | +51.7% (Apr 22, 2015) |
| Weeks tracked | 418 |
| Tracking since | May 21, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+2.6%
5Y
+2.6%
All
+50.7%
Last surveyed Aug 13, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CODEINE PHOSPHATE and GUAIFENESIN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Marnel Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CODEINE PHOSPHATE and GUAIFENESIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MAR-COF CG LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for MAR-COF CG LIQUID, manufactured by Marnel Pharmaceuticals, Inc., is $0.1471 per ML (NDC 00682047516), effective Aug 13, 2025.
How has the price of MAR-COF CG LIQUID changed over time?
Over the history we have for it, the NADAC for MAR-COF CG LIQUID has risen 50.7%. It has been tracked across 418 weekly CMS publications since May 21, 2014.
What are the highest and lowest recorded NADAC prices for MAR-COF CG LIQUID?
Since May 21, 2014, the NADAC for MAR-COF CG LIQUID has ranged from a low of $0.0976 (May 21, 2014) to a high of $0.1557 (Feb 10, 2016), with a median of $0.1441 per ML.
Are there cheaper alternatives to MAR-COF CG LIQUID?
No other NADAC-published product currently shares the active ingredient and strength of MAR-COF CG LIQUID in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MAR-COF CG LIQUID?
MAR-COF CG LIQUID (NDC 00682047516) is labeled by Marnel Pharmaceuticals, Inc., and CMS classifies it as a generic product.